LexDanaLexDanabeta
Inventor

Konstanze Hurth

Inventor
Saint-Louis, FR

Overview

27→
Patents
2005–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes26%
C07BGeneral methods of organic chemistry7%
C12NMicroorganisms or enzymes2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,683,287Heterocyclic derivatives and their use in the treatment of neurological disorders202010,301,296Heterocyclic derivatives and their use in the treatment of neurological disorders201910,035,794Heterocyclic derivatives and their use in the treatment of neurological disorders20189,849,117Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists20179,840,498'Substituted quinazolin-4-one derivatives'20179,763,952'Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives'20179,657,010'Substituted quinuclidines as alpha 7-nicotinic acetylcholine receptor activity modulators'20179,567,343'Aza-bicyloalkyl ethers and their use as alpha7-nachr agonists'20179,550,758'Heterocyclic derivatives and their use in the treatment of neurological disorders'20179,539,260'Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives'20179,475,811'1-aza-bicyclo[3.3.1]nonanes'20169,284,284'Oxazine derivatives and their use in the treatment of disease'20169,206,181'1-aza-bicyclo[3.3.1] non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders'20159,012,451'Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists'20158,933,090'1-aza-bicyclo[3.3.1]nonanes'20158,865,712'Heterocyclic derivatives and their use in the treatment of neurological disorders'20148,759,346'Organic compounds'20148,637,517'Organic compounds'20148,637,508'Heterocyclic derivatives and their use in the treatment of neurological disorders'20148,609,662'3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases'20138,236,803'Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists'20128,048,885'Organic compounds'20117,754,719'Substituted piperidine derivatives as somatostatin SST1 receptor antagonists'20107,713,976'[(1H-indol-5-yl)-heteroaryloxy]-1-aza-bicylco[3.3.1]nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders'20107,713,977'(1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders'20107,579,362'Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists'20096,861,430'β-carboline derivatives and its pharmaceutical use against depression and anxiety'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2020Patents assigned to NOVARTIS AG (27)· patent assignee history
2005–2017Based in Saint-Louis, FR· patent location history
2012–2017Patents assigned to HURTH KONSTANZE (12)· patent assignee history
2012–2015Patents assigned to FEUERBACH DOMINIK (6)· patent assignee history
2013–2015Patents assigned to FREDERIKSEN MATHIAS (4)· patent assignee history
2014–2017Patents assigned to JACQUIER SEBASTIEN (5)· patent assignee history
2014–2020Based in Lorrach, DE· patent location history
2014Based in Loerrach, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVARTIS AG272005–2020
HURTH KONSTANZEself122012–2017
FEUERBACH DOMINIK62012–2015
JACQUIER SEBASTIEN52014–2017
FREDERIKSEN MATHIAS42013–2015
Locations
LocationPatentsSpan
Saint-Louis, FR172005–2017
Lorrach, DE92014–2020
Loerrach, DE12014